The Egyptian Organization for Biotechnology and Human Genetics
Research
Molecular diagnostics in Genotyping and Posttranscriptional regulation
control of Pharmacogenetics in Autoimmune diseases and Cancers
Contact person details
Name:
SALEH , Hatem ( Dr)
Position:
Head of Genetics unit of Diabetes - Human genetics research
Department
Name of
Organisation:
The Egyptian organization of Biotechnologty
URL:
E-mail:
Contact
Telephone:
+20-166-280349
Fax number:
Collaboration
Type: Project Proposal
Title: Molecular diagnostics in Genotyping and Posttranscriptional regulation control
of Pharmacogenetics in Autoimmune diseases and Cancers
Participation: Type A
Type Details: EGYTEC-VACSERA is a science-driven biotechnology organization
focused on early -stage discovery research of human genetics diseases to help
accelerate research and development therapeutic compounds. EGYTEC is specialized
in molecular diagnostics for medical applications as in Genotyping, Molecular
Cloning, Gene Expression, Characterization of the role of genes starting from
Genotyping until the Gene expression to synergize with molecular genetics for
identification of genes underling Complex diseases, Posttranscriptional Regulation
Control Mechanism of mRNA, Bioinformatics, DNA Biosensors, Development of DNA
mircoarray Chip for Detection of SNPs in Genes associated with diseases by using
DNA mircoarray. Development of cDNA mircoarray Chip for detection of gene
expression by using cDNA mircoarray and we have to access to large characterized
populations and have the capability to collect thousands of samples of complex
diseases.
Programme: FP7 , FP7-COOPERATION , FP7-CAPACITIES , FP7-PEOPLE , FP7HEALTH , FP7-NMP , FP7-INFRASTRUCTURES , FP7-REGIONAL , FP7-SME , GALILEO
Instruments: NoE Networks of Excellence,CSA-CA Coordination (or networking)
actions,CSA-SA Support actions,BSG-SME Research for SMEs,BSG-SME-AG Research
for SME associations/groupings,CP-FP Small or medium-scale focused research
project,CP-IP Large-scale integrating project,CP-TP Collaborative Project targeted to
a special group (such as SMEs),ERC-ER1 Experienced researchers 1st stage,ERC-YR
Young researchers,MC-AWARDS Awards (AWARDS),MC-COFUND Co-funding of
Regional, National and International Programmes (COFUND),MC-ERG European Reintegration Grants (ERG),MC-IIF International Incoming Fellowships (IIF),MC-IOF
International Outgoing Fellowships (IOF),MC-IRG International Re-integration Grants
(IRG),NULLERC-ER2 Experienced researchers 2nd stage,CP-SICA Collaborative
project for specific cooperation actions dedicated to international cooperation partner
countries (SICA)
Research interest:
Expiry Date: 2008-12-06
Workprogramme area(s)/key action(s):
(FP7-HEALTH HEALTH-2007-2) Translating research for human health
(FP7-HEALTH HEALTH-2007-2.4.2) Cardiovascular disease
(FP7-HEALTH HEALTH-2007-2.1.1) Large scale data gathering
(FP7-HEALTH HEALTH-2007-2.4.3) Diabetes and obesity
(FP7-NMP NMP-1) Nanosciences and Nanotechnologies
(FP7-PEOPLE PEOPLE-2007-4-2.IIF) Marie Curie Action: "International Incoming
Fellowships"
(FP7-HEALTH HEALTH-1) Biotechnology, generic tools and medical technologies for
human health
(FP7-PEOPLE PEOPLE-2007-2-3.COFUND) Marie Curie Action: "Co-funding of
Regional, National and International Programmes "
(FP7-PEOPLE PEOPLE-2007-1-1.ITN) Marie Curie Action: "Networks for Initial
Training"
(FP7-PEOPLE PEOPLE-1) Initial training of researchers
(FP7-HEALTH HEALTH-2007-2.3) Translational research in major infectious diseases:
To confront major threats to public health
(FP7-HEALTH HEALTH-2007-2.4) Translational research in other major diseases
(FP7-PEOPLE PEOPLE-2) Life-long training and career development
(FP7-HEALTH HEALTH-2007-1.2) Detection, diagnosis and monitoring
(FP7-PEOPLE PEOPLE-2007-2-2.ERG) Marie Curie Action: "European Reintegration
Grants"
(FP7-HEALTH HEALTH-2007-2.4.1) Cancer
Target Partner
Expertise:
- Biosensors and bioassays,bio-nano-technological approaches ( optical sensors,
cromo-flurogenic and electrochemical sensors.
- Bioinformatics.
- Pharmacocogenomics and pharmacogenetics approach.
- New Molecular Mechanism that could be used in Molecular Human Genetics
diagnostics systems.
- Epigenetic applications in Gene therapy for autoimmune diseases (as diabetes,
goiter...etc), cancer and leukemia in human.
- siRNA and miRNAs mircoarray analyses and their application in the treatment of
autoimmune diseases as (Diabetes, Goiter,...etc), Cancer and Leukemia.
- Developing systems to study functionally overexpress the relevant genes or
altering their expression using small interfering RNA(siRNA).
- Discovery of new genes as study their functions related to their progress of the
diseases
- Human molecular diseases identification application which could include
technologies based on DNA.
- Molecular Epidemiological Characterization studies variation of human and
associated genes caused diseases as Diabetes in autoimmune diseases, Cancer and
Leukemia diseases.
- Comparative studies of genetic variation of human and associated genes caused
the inherited diseases.
- Biomarker in Cancer
- Biomarker in autoimmune diseases.
- Translating the knowledge on non coding RNAs linked to the aetiology of
autoimmune diseases as Diabetes, Cancer and leukemia
- Pathogenesis of Type 1 diabetes including Geno/Pheno typing of Type 1 diabetes.
- Developing Real time PCR for quantifying the gene expression related to the
progress of the diseases as autoimmune diseases as Diabetes, Cancer and Leukemia.
- Proteomics and Metabolomics applications in the treatment of the diseases
Country: Any country
Organization Details
Name:
The Egyptian organization of Biotechnologty
Department:
Address:
Teret El sawahel street, Block 19, flat # 3
12411
Imbaba- Cairo
ESPAÑA
Type:
Consultancy, Research, Education, Industry, Technology
transfer, Non Commercial, SME (Small or Medium sized
Enterprise)
Number of
Employees:
50 - 249
Details:
Turnover:
20 million euro
SIC Codes:
Biotechnology , Medical biotechnology , Medicine, Health ,
Nanotechnology and Nanosciences
Keywords:
Diabetes
Cancer
Leukemia
health sciences
biosensors
geneexpression
RealtimePCR
mircoarray
pharmacogenetics
Biotechnology
Posttranscription
Partners already
acquired: